Added to YB: 2026-08-10
Pitch date: 2026-08-10
BSX [bullish]
Boston Scientific Corporation
+0.2%
current return
Author Info
CEO Watcher tracks insider trades (and calculates the track record of every insider) to find the highest signal trades. Looking for dip buys, reversals, cluster buys, insider with a strong track record, etc. Sign up for the newsletter.
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$73.0B
Pitch Price
$50.27
Price Target
N/A
Dividend
N/A
EV/EBITDA
14.94
P/E
20.41
EV/Sales
4.06
Sector
Health Care Equipment and Supplies
Category
value
CEO buys $9mm of medical device company's stock after 29 straight sales
BSX: Insider-signal bottom-fishing bet: Chairman/CEO bought $9mm at $48.33 (his 1st-ever buy after 29 straight sales), joining 2 directors—classic dip+cluster+reversal. Stock -55% 1y on 3 straight guide-downs (WATCHMAN weakness, EP share loss, CMS payment cuts); 2026 organic growth cut 10-11%→5-6%, EPS to $3.28-3.32. Now at lowest P/E since 2012 and 14.6x EV/EBITDA vs 27.5x 5y median. Thesis: worst case is priced in and sentiment inflecting—July's 10% earnings dip erased next day, +15% off lows. Key risk: changed physician behavior (more 'wait-and-see' post-ablation) could drive further WATCHMAN cuts, though it's <10% of revenue; $500mm restructuring savings targeted by 2027.
Read full article (4 min)